CYTOKINETICS INC Quarterly Interest Expense in USD from Q3 2015 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Cytokinetics Inc quarterly/annual Interest Expense history and growth rate from Q3 2015 to Q2 2024.
  • Cytokinetics Inc Interest Expense for the quarter ending June 30, 2024 was $12.7M, a 80.7% increase year-over-year.
  • Cytokinetics Inc Interest Expense for the twelve months ending June 30, 2024 was $34.1M, a 22.5% increase year-over-year.
  • Cytokinetics Inc annual Interest Expense for 2023 was $28.3M, a 45.8% increase from 2022.
  • Cytokinetics Inc annual Interest Expense for 2022 was $19.4M, a 18.1% increase from 2021.
  • Cytokinetics Inc annual Interest Expense for 2021 was $16.4M, a 2.99% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $34.1M $12.7M +$5.69M +80.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $28.4M $7.1M +$142K +2.04% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $28.3M $7.16M +$107K +1.52% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 $28.2M $7.14M +$332K +4.88% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $27.9M $7.05M +$4.24M +151% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 $23.6M $6.96M +$4.22M +153% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $19.4M $7.06M +$2.84M +67.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 $16.6M $6.8M +$2.64M +63.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 $13.9M $2.81M -$1.27M -31.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $15.2M $2.75M -$1.24M -31.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q4 2021 $16.4M $4.22M +$200K +4.98% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 $16.2M $4.16M +$185K +4.65% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 $16.1M $4.07M +$181K +4.65% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 $15.9M $3.99M -$89K -2.18% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 $16M $4.02M +$1.29M +47.1% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 $14.7M $3.98M +$2.63M +196% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 $12M $3.89M +$2.52M +183% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $9.53M $4.08M +$2.91M +248% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $6.62M $2.73M +$1.56M +134% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-25
Q3 2019 $5.06M $1.35M +$478K +55.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $4.58M $1.38M +$479K +53.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $4.1M $1.17M +$307K +35.6% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 $3.8M $1.17M +$486K +71.2% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-26
Q3 2018 $3.31M $867K +$61K +7.57% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-01
Q2 2018 $3.25M $898K +$116K +14.8% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $3.13M $863K +$118K +15.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $3.02M $683K -$31K -4.34% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-07
Q3 2017 $3.05M $806K +$92K +12.9% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 $2.96M $782K +$75K +10.6% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $2.88M $745K +$182K +32.3% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $2.7M $714K Oct 1, 2016 Dec 31, 2016 10-K 2018-03-05
Q3 2016 $714K +$714K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-03
Q2 2016 $707K Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-04
Q1 2016 $563K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q3 2015 $0 Jul 1, 2015 Sep 30, 2015 10-Q/A 2016-12-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.